Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $3.62 in the prior trading day, Atea Pharmaceuticals Inc (NASDAQ: AVIR) closed at $3.74, up 3.17%. In other words, the price has increased by $3.17 from its previous closing price. On the day, 0.29 million shares were traded. AVIR stock price reached its highest trading level at $3.7599 during the session, while it also had its lowest trading level at $3.65.
Ratios:
Our goal is to gain a better understanding of AVIR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.94 and its Current Ratio is at 19.94. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on August 13, 2024, Upgraded its rating to Equal-Weight and sets its target price to $6.88 from $2 previously.
Morgan Stanley Downgraded its Equal-Weight to Underweight on January 06, 2022, whereas the target price for the stock was revised from $14 to $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 10 ’24 when BERGER FRANKLIN M sold 359,606 shares for $2.85 per share. The transaction valued at 1,023,475 led to the insider holds 451,897 shares of the business.
Franklin Berger bought 359,606 shares of AVIR for $1,023,475 on Dec 10 ’24. On Sep 17 ’24, another insider, Sommadossi Jean-Pierre, who serves as the President, CEO, and Chairman of the company, sold 33,941 shares for $4.05 each. As a result, the insider received 137,318 and left with 5,890,053 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVIR now has a Market Capitalization of 320067360 and an Enterprise Value of -115904888.
Stock Price History:
The Beta on a monthly basis for AVIR is 0.25, which has changed by 0.15076923 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, AVIR has reached a high of $4.14, while it has fallen to a 52-week low of $2.45. The 50-Day Moving Average of the stock is 21.90%, while the 200-Day Moving Average is calculated to be 17.65%.
Shares Statistics:
The stock has traded on average 440.33K shares per day over the past 3-months and 448870 shares per day over the last 10 days, according to various share statistics. A total of 85.58M shares are outstanding, with a floating share count of 69.36M. Insiders hold about 18.96% of the company’s shares, while institutions hold 59.38% stake in the company. Shares short for AVIR as of 1749772800 were 3319297 with a Short Ratio of 7.54, compared to 1747267200 on 3244483. Therefore, it implies a Short% of Shares Outstanding of 3319297 and a Short% of Float of 4.8699997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
